Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Omar H Butt, M.D., Ph.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Rochester, Minnesota, United States
Jian L Campian, M.D., Ph.D. - Washington University School of Medicine
St Louis, Missouri, United States
Albert H Kim, M.D., Ph.D.Dimitrios Mathios, M.D.Eric Leuthardt, M.D.Jingqin (Rosy) Luo, Ph.D.Milan Chheda, M.D.Omar H Butt, M.D., Ph.D.Tanner M Johanns, M.D., Ph.D.Yu (Jade) Tao, M.D.
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2026
- Primary completion
- 28 Feb 2031
- Completion
- 31 Aug 2032
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 99
- Registry id
- NCT07620548
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.